Nevro Appoints Karen N. Prange to the Company's Board of Directors

REDWOOD CITY, Calif., Dec. 18, 2019 -- (Healthcare Sales & Marketing Network) -- Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today announced that its B... Devices, Neurology, Personnel Nevro Corp, Senza Omnia, Spinal Cord Stimulation, HF10 therapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news